Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland

Overview of attention for article published in Breast Cancer Research and Treatment, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy: 1 policy source

twitter: 5 X users

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 15,262 followers.

RT @DirectorNCCP: @susanmsmith @IrishTimes Here are some Irish data on tumour genetics and chemo-avoidance: The impact of Oncotype DX test…

19 Aug 2019

Reply Repost Favourite

RT @DirectorNCCP: @susanmsmith @IrishTimes Here are some Irish data on tumour genetics and chemo-avoidance: The impact of Oncotype DX test…

19 Aug 2019

Reply Repost Favourite

@susanmsmith @IrishTimes Here are some Irish data on tumour genetics and chemo-avoidance: The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre https://t.co/4zYqxr4VU7. Some cost

06 Aug 2019

Reply Repost Favourite

RT @CancerPapers: Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland. http://t.co/PbIkUd7ceT #brea…

05 Oct 2015

Reply Repost Favourite

Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland. http://t.co/PbIkUd7ceT #breastcancer

14 Sep 2015

Reply Repost Favourite